You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
A STUDY ON SELECTED APPROVED NEW CHEMICAL ENTITIES BY USFDA AND FORECASTING THE UNIT SALES IN THE PROPOSED GENERIC R&D PORTFOLIO
- In: Poster Session
- At: Düsseldorf (Germany) (2015)
- Type: Poster
- By: AJAY, Maram (Manipal College of Pharmaceutical Sciences, Manipal University, Hyderabad, India)
- Co-author(s): N Udupa
- Abstract:
Generic drugs are considered as an economical alternative to innovator drugs yet keeping in mind the quality, safety and efficacy intact. Generic drugs have gained a major interest due to various reasons like economic factors due to which major Indian companies entered generic market places through various regulatory approvals like USFDA in the..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026